company background image
A170900 logo

Dong-A ST KOSE:A170900 Stock Report

Last Price

₩75.30k

Market Cap

₩649.7b

7D

2.6%

1Y

42.2%

Updated

28 Mar, 2024

Data

Company Financials +

Dong-A ST Co., Ltd.

KOSE:A170900 Stock Report

Market Cap: ₩649.7b

A170900 Stock Overview

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

A170900 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Dong-A ST Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dong-A ST
Historical stock prices
Current Share Price₩75,300.00
52 Week High₩88,000.00
52 Week Low₩47,745.10
Beta0.72
1 Month Change7.27%
3 Month Change8.97%
1 Year Change42.23%
3 Year Change-6.18%
5 Year Change-18.39%
Change since IPO-47.24%

Recent News & Updates

Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Mar 25
Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Mar 07
Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Recent updates

Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Mar 25
Dong-A ST's (KRX:170900) Shareholders Have More To Worry About Than Only Soft Earnings

Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Mar 07
Dong-A ST Co., Ltd. (KRX:170900) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Does Dong-A ST (KRX:170900) Have A Healthy Balance Sheet?

Apr 09
Does Dong-A ST (KRX:170900) Have A Healthy Balance Sheet?

Dong-A ST's (KRX:170900) Problems Go Beyond Weak Profit

Mar 23
Dong-A ST's (KRX:170900) Problems Go Beyond Weak Profit

A Look At The Fair Value Of Dong-A ST Co., Ltd. (KRX:170900)

Mar 12
A Look At The Fair Value Of Dong-A ST Co., Ltd. (KRX:170900)

A Look At Dong-A ST's (KRX:170900) Share Price Returns

Feb 24
A Look At Dong-A ST's (KRX:170900) Share Price Returns

Is Dong-A ST Co., Ltd.'s (KRX:170900) Stock's Recent Performance A Reflection Of Its Financial Health?

Feb 09
Is Dong-A ST Co., Ltd.'s (KRX:170900) Stock's Recent Performance A Reflection Of Its Financial Health?

Is Dong-A ST Co., Ltd. (KRX:170900) Popular Amongst Institutions?

Jan 25
Is Dong-A ST Co., Ltd. (KRX:170900) Popular Amongst Institutions?

Is Dong-A ST Co., Ltd. (KRX:170900) A Good Fit For Your Dividend Portfolio?

Jan 11
Is Dong-A ST Co., Ltd. (KRX:170900) A Good Fit For Your Dividend Portfolio?

Be Sure To Check Out Dong-A ST Co., Ltd. (KRX:170900) Before It Goes Ex-Dividend

Dec 25
Be Sure To Check Out Dong-A ST Co., Ltd. (KRX:170900) Before It Goes Ex-Dividend

Dong-A ST (KRX:170900) Has A Rock Solid Balance Sheet

Dec 22
Dong-A ST (KRX:170900) Has A Rock Solid Balance Sheet

Calculating The Intrinsic Value Of Dong-A ST Co., Ltd. (KRX:170900)

Dec 07
Calculating The Intrinsic Value Of Dong-A ST Co., Ltd. (KRX:170900)

A Look At Dong-A ST's (KRX:170900) Share Price Returns

Nov 19
A Look At Dong-A ST's (KRX:170900) Share Price Returns

Shareholder Returns

A170900KR PharmaceuticalsKR Market
7D2.6%4.3%2.4%
1Y42.2%28.2%12.2%

Return vs Industry: A170900 exceeded the KR Pharmaceuticals industry which returned 28.2% over the past year.

Return vs Market: A170900 exceeded the KR Market which returned 12.2% over the past year.

Price Volatility

Is A170900's price volatile compared to industry and market?
A170900 volatility
A170900 Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.9%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A170900 has not had significant price volatility in the past 3 months.

Volatility Over Time: A170900's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19321,663Min-Young Kimhttps://www.donga-st.com

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim injection for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and anovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Leucostim for the treatment of neutropenia in patients receiving myelosuppressive chemotherapy; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen tab for the treatment of gastritis; Suganon tab for diabetes treatment; Terizidone tab for active pulmonary and extra-pulmonary tuberculosis; and Zydena tab for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high-technology medical devices, custom-made products, and sets of artificial cardiac circuits for use in open-heart surgery.

Dong-A ST Co., Ltd. Fundamentals Summary

How do Dong-A ST's earnings and revenue compare to its market cap?
A170900 fundamental statistics
Market cap₩649.65b
Earnings (TTM)₩11.12b
Revenue (TTM)₩663.98b

57.4x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A170900 income statement (TTM)
Revenue₩663.98b
Cost of Revenue₩339.31b
Gross Profit₩324.67b
Other Expenses₩313.55b
Earnings₩11.12b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.31k
Gross Margin48.90%
Net Profit Margin1.68%
Debt/Equity Ratio58.5%

How did A170900 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

152%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.